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Abstract 
Pulmonary rehabilitation is effective for improving exercise capacity in patients with interstitial 
lung disease (ILD), and most programs last about 8 weeks. A 43-year-old male patient with 
systemic sclerosis and oxygen saturation (SpO2) declining because of severe ILD was 
hospitalized for treatment of chronic skin ulcers. During admission, he completed a 27-week 
walking exercise program with SpO2 monitoring. Consequently, continuous walking distance 
without severe hypoxia (SpO2 > 90%) increased from 60 m to 300 m after the program, 
although his six-minute walking distance remained the same. This suggests that walking 
exercise for several months may reduce the risk of hypoxia in patients with ILD, even though 
exercise capacity does not improve. 
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Introduction 
Systemic sclerosis is a multisystem disease with pulmonary involvement, which decreases 
exercise capacity and is related to survival.1,2 Medication and exercise training have recently 
been shown to improve dyspnea, six-minute walking distance, maximum heart rate, and quality 
of life.3 Most training studies4,5 have been performed using 8-week programs based on 
pulmonary rehabilitation used in the treatment of chronic obstructive pulmonary disease.6,7 This 
study was performed to evaluate the effects of a rehabilitation program including walking 
training over a 6-month period in a patient with systemic sclerosis and to determine any 
improvement in exercise capacity. 
 
Case Report 
A 43-year-old male patient with systemic sclerosis and ILD was admitted with chronic 
ulceration of  his fingers. He had been treated for 4 years with corticosteroids, and at a dose of 
10 mg for the 4 months prior to presentation. His lifestyle was sedentary and he had refused 
home oxygen therapy. He lived independently, including being able to drive. His Hugh-Jones 
grade was 3, ie, he was unable to keep up with healthy persons walking on the level, but was 
able to walk for one mile (1.6 km) or more at a slower speed. 
 On admission, forced vital capacity was 61.5% and carbon monoxide diffusion 
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capacity (DLCO) was 29.8% of predicted. Blood gas analysis showed a PaO2 of 74 mmHg and 
PaCO2 of 39 mmHg. Right ventricular systolic pressure was 39 mmHg and mean pulmonary 
artery pressure was 18 mmHg. His six-minute walking distance was 521 m, with oxygen 
saturation (SpO2) declining from 96% at rest to 72% at completion, determined using a 
handheld pulse oximeter with a reflectance sensor on the forehead. Perceived exertion increased 
from 0 to 4 on the Borg 10 scale. Walking distance without rest was 60 m when SpO2 declined 
to 85%. 
 After admission to hospital, the corticosteroid dose was kept the same as before, but 
bosentan, sildenafil, and prostacyclin derivatives were added to treat the ulcers. The 
prostacyclin dose was increased during the first 8 weeks of admission, and then remained 
unchanged until discharge.  
 The rehabilitation program included walking training, training for leg muscle 
strengthening with a sand weight of 2.5 kg on the mat, and additional stretching exercise for the 
fingers because of sclerotic skin changes. The total time spent exercising was about one hour 
per day on 5 days per week. The patient gave informed consent to these rehabilitation treatments 
before starting the program. On the first day of walking training, 60 m walking in one minute 
was performed based on the first evaluation and was repeated with rest intervals of a few 
minutes. The total walking training time was 20 to 30 minutes per day. Training distance 
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without rest increased when SpO2 was above 90% during training. 
 Figure 1 shows the training walking distance starting from 60 m, increasing gradually 
to 300 m after 27 weeks of training. The six-minute walking distance, evaluated five times, was 
about 500 m, and perceived exertion in the fifth test also increased from 0 to 4 on the Borg scale, 
while the end value of SpO2 was increased. At discharge, when the finger ulcers had resolved, 
forced vital capacity was 59.8% and DLCO was 24.2% of predicted. Right ventricular systolic 
pressure was 36 mmHg and mean pulmonary artery pressure was 19 mmHg, suggesting little 
change in cardiopulmonary function. 
 
Discussion 
This patient showed no improvement in six-minute walking distance. In COPD patients, the 
minimal important difference for a six-minute walking distance test is 25 m,8 and was 22 m in 
this patient. One of the exclusion criteria for the six-minute walking test is an initial resting 
SpO2 < 90%.9 However, there are no clear criteria to discontinue the test in relation to low SpO2. 
The final SpO2 in this patient was 72%–80%, showing slight improvement, although these 
values were thought to be harmful to his circulation. Because this patient had no severe dyspnea 
during the six-minute walking test, it was recommended that he continue most of his daily 
activities despite the low oxygen saturation which might have been causing his finger ulcers. 
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During training in ILD, Holland et al3 set the lowest SpO2 to 85%. Progressive 
walking training was introduced by Nava10 in stepwise rehabilitation following acute respiratory 
failure. High-intensity interval exercise training for COPD is effective in inducing peripheral 
muscle adaptation, with less dyspnea compared with constant-load exercise.11 These studies are 
encouraging with regard to interval walking training (SpO2 > 90%) for ILD patients. Exercise 
training was beneficial to our patient in reducing the risk of hypoxia during walking up to 300 m. 
Thus, exercise training would be effective in improving safety, considering both hemodynamics 
and skin ulcer recurrence. 
Some medications for pulmonary arterial hypertension were added to treat the ulcers. 
Bosentan is reported to have no effect on the six-minute walking distance in idiopathic 
pulmonary fibrosis,12 whereas prostacyclin derivatives improved six-minute walking distance 
test in systemic sclerosis with pulmonary arterial hypertension.12 These medications for 
pulmonary arterial hypertension did not improve cardiopulmonary function nor exercise 
capacity in our patient.  
  
Conclusion 
Generally, exercise training for lung disease is known to increase exercise capacity over 8 
weeks. Although the six-minute walking distance in this patient was about 500 m and did not 
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change after exercise training, the risk of hypoxia was remarkably reduced up to 300 m of 
walking. This case report suggests a benefit of exercise training to ameliorate hypoxia in 
addition to improving exercise capacity. 
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Figure 1 
Following walking exercise, training distance (●) increased during the intervention period. 
Six-minute walking test (■) showed no marked changes, while end %SpO2 of the test (▲) 
improved. 
 
 
 
